↓ Skip to main content

Michigan Publishing

A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)COXEN Neoadjuvant Biomarker Trial in Bladder Cancer

Overview of attention for article published in Clinical Cancer Research, February 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
twitter
36 X users

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
36 Mendeley
Title
A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)COXEN Neoadjuvant Biomarker Trial in Bladder Cancer
Published in
Clinical Cancer Research, February 2021
DOI 10.1158/1078-0432.ccr-20-2409
Pubmed ID
Authors

Thomas W. Flaig, Catherine M. Tangen, Siamak Daneshmand, Ajjai Alva, Seth P. Lerner, M. Scott Lucia, David J. McConkey, Dan Theodorescu, Amir Goldkorn, Matthew I. Milowsky, Rick Bangs, Gary R. MacVicar, Bruno R. Bastos, Jared S. Fowles, Daniel L. Gustafson, Melissa Plets, Ian M. Thompson

X Demographics

X Demographics

The data shown below were collected from the profiles of 36 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 22%
Other 3 8%
Student > Postgraduate 3 8%
Student > Bachelor 2 6%
Student > Doctoral Student 1 3%
Other 6 17%
Unknown 13 36%
Readers by discipline Count As %
Medicine and Dentistry 15 42%
Biochemistry, Genetics and Molecular Biology 2 6%
Unspecified 1 3%
Nursing and Health Professions 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 2 6%
Unknown 14 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2022.
All research outputs
#1,176,140
of 23,724,077 outputs
Outputs from Clinical Cancer Research
#812
of 12,805 outputs
Outputs of similar age
#35,251
of 516,188 outputs
Outputs of similar age from Clinical Cancer Research
#43
of 367 outputs
Altmetric has tracked 23,724,077 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,805 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 516,188 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 367 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.